Virginia Cancer Institute

What Virginia Cancer Institute does

Virginia Cancer Institute (VCI) is a private medical oncology and hematology practice founded in 1981 and headquartered in the Greater Richmond, Virginia region. The practice delivers comprehensive cancer and blood-disorder care — including chemotherapy, radiation therapy, surgery, hormonal therapy, targeted therapy, and both autologous and allogeneic stem cell transplantation — across seven physical clinic locations supported by 25+ physicians and 300+ total staff. It serves oncology and hematology patients referred by primary care physicians, by specialists, or via self-referral, and also accepts second-opinion patients and provides caregiver support resources. In-house diagnostic imaging (CT and PET), a clinical trials program covering phases II–IV, and a digital patient portal (CareSpace Portal) round out the clinical and operational stack.

The practice generates revenue through fee-for-service medical billing to insurance carriers and patients. Copayments, coinsurance, and deductibles are collected at the time of service, with self-pay patients expected to pay in full; online bill pay is available through a third-party processor (POS Corp). New patient registration is digitized through online forms, and existing patients manage scheduling, records, and care communications via the CareSpace Portal. Supporting operational infrastructure includes a business office in Henrico handling billing and insurance verification across all seven locations.

VCI's physicians have been invited by the American Society of Clinical Oncology (ASCO) to help define national standards for quality cancer practices, an unusual designation for a community-based practice that positions the group as a clinical thought leader. The practice operates without disclosed parent-company ownership, venture capital, or private equity investment, and no public filings or disclosed revenue figures were found in the source materials.

Name

Virginia Cancer Institute

Legal name

Virginia Cancer Institute

Website

https://vacancer.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

251–500 employees

Short description

Virginia Cancer Institute is a private medical oncology and hematology practice founded in 1981, operating seven clinics in the Greater Richmond, Virginia region with 25+ physicians and 300+ staff delivering chemotherapy, radiation, imaging, stem cell transplantation, and clinical trials.

Ownership category

akta.pro rank

Product category

Oncology Care Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Radiation Oncology (HLAKAFAC), Surgical Oncology (HLAKAFAG)

Keywords

• Oncology treatment services
• Hematology care
• Cancer diagnosis imaging
• Clinical trials oncology
• Chemotherapy infusion

Headquarters

HQ city

Richmond

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Medical Services Revenue: Revenue generated from patient medical services including consultations, chemotherapy administration, radiation therapy, diagnostic imaging (CT/PET scans), laboratory tests, and other cancer treatments. Services are billed to insurance carriers or patients directly.
2. Clinical Trial Services: Revenue from participation in clinical trials, which may include compensation for treatment administration and monitoring as part of research protocols.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Virginia Cancer Institute is a private medical oncology and hematology practice delivering comprehensive cancer diagnosis and treatment for adult patients. Services include chemotherapy, radiation therapy, surgery, hormonal therapy, targeted therapy, biological therapy, stem cell transplantation, and CT/PET diagnostic imaging, supported by an in-house clinical trials program and an online patient portal. Care is delivered by 25+ physicians and 300+ staff across seven locations in the Greater Richmond, Virginia region.

Product overview

Virginia Cancer Institute is a medical oncology practice offering a comprehensive suite of cancer and blood disorder treatment services. Founded in 1981, it operates as a single unified healthcare practice with 25+ physicians and 300+ staff across 7 locations in the Greater Richmond, Virginia region. The practice integrates multiple treatment modalities including chemotherapy, radiation therapy, surgery, hormonal therapy, targeted therapy, and stem cell transplantation. Supporting services include CT & PET imaging, a clinical trials program, patient portal access, online bill pay, and digital patient forms. The organization partners with the American Society of Clinical Oncology to help define quality standards for cancer care practices.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncology and Hematology Medical Services Comprehensive cancer and blood disorder diagnosis and treatment services provided by 25+ physicians and 300+ staff across seven locations in the Greater Richmond region, covering all major oncology and hematology care for adult patients.
• Chemotherapy Treatment Systemic drug treatment delivered via oral, intravenous, intrathecal, intramuscular, or intracavitary methods, using single-agent or combination regimens, with venous access devices such as Hickman catheters and port-a-caths for long-term access.
• Radiation Therapy High-energy radiation delivered externally or via internal (brachytherapy) methods to damage or destroy cancer cells and prevent tumor growth.
• Surgical Oncology Oncologic surgical procedures including biopsies and tumor resection performed in offices, affiliated hospitals, or outpatient surgery centers.
• Hormonal Therapy Drug therapy that blocks hormone production or alters hormone function to treat hormone-sensitive cancers such as breast and prostate cancer.
• Targeted Therapy Precision drug regimens designed to act on specific molecular targets on cancer cells, limiting damage to healthy tissue and reducing side effects.
• Stem Cell Transplantation Autologous and allogeneic stem cell transplantation procedures for eligible patients with hematologic malignancies and lymphoid cancers.
• CT & PET Imaging Services State-of-the-art CT and PET imaging for cancer diagnosis, initial staging, treatment response evaluation, and routine follow-up, with 24-hour standard turnaround and same-day scheduling available in special circumstances.
• Clinical Trials Program Access to cancer clinical trials spanning phases II, III, and IV, providing patients with investigational drugs and treatment strategies not yet widely available.

Quantifiable outcome

• 24-hour standard imaging service from first call through reading of results
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• American Society of Clinical Oncology (ASCO)coreStrategic or Co-development PartnerVirginia Cancer Institute physicians were invited to help ASCO define the standards for quality cancer practices in the United States. This recognition demonstrates the high caliber of the practice's physicians and their contribution to shaping oncology care standards nationally.

Scale indicators4 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• Florida Cancer Specialists & Research Institute: Large physician-owned community oncology and hematology practice with extensive Florida footprint. Comparable in scale, multi-site delivery model, and emphasis on clinical trials and in-house imaging.
• Texas Oncology: One of the largest US community oncology practices, operating more than 200 sites across Texas. Comparable to VCI as a multi-site medical oncology and hematology group providing chemotherapy, radiation, imaging, and clinical trials.
• Tennessee Oncology: Large multi-site community oncology and hematology practice based in Nashville. Closely comparable to VCI in offering medical oncology, infusion, imaging, and clinical trials through a physician-led regional platform.
• Compass Oncology: Multi-site community oncology and hematology practice in Oregon and Washington. Comparable to VCI in service mix, multi-site physician-led structure, and clinical trial offerings.
• Willamette Valley Cancer Institute: Community oncology practice serving Oregon with multiple locations. Comparable to VCI as a regional medical oncology and hematology group offering imaging, infusion, and clinical trials.
• New York Oncology Hematology (NYOH): Regional community oncology and hematology practice serving the Albany, New York region. Comparable to VCI in scope of services, multi-site structure, and community-based delivery.
• OHC (Oncology Hematology Care): Independent community oncology and hematology practice based in Cincinnati with multiple locations. Comparable to VCI in delivery of medical oncology, infusion, imaging, and clinical trials in a regional footprint.

Broad incumbents

• American Oncology Network: National network of community oncology practices. Comparable as a broader platform for community oncology delivery that competes with independent regional practices like VCI for physicians and referrals.
• City of Hope: National cancer treatment and research system including former Cancer Treatment Centers of America sites. Comparable as a higher-acuity competitor that draws complex oncology cases away from community practices like VCI.

Regional players

• VCU Massey Comprehensive Cancer Center: NCI-designated academic cancer center serving the same Richmond, Virginia market. Comparable as a local competitor with deeper subspecialty expertise and research infrastructure that competes with VCI for higher-acuity oncology cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/vacancerinstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virginia Cancer Institute